|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM216404258 |
003 |
DE-627 |
005 |
20231224031659.0 |
007 |
tu |
008 |
231224s2010 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed24n0721.xml
|
035 |
|
|
|a (DE-627)NLM216404258
|
035 |
|
|
|a (NLM)22439053
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Pappalardo, Elisa Maria
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Uterine rupture after prostaglandin analogues to induce midtrimester abortion
|
264 |
|
1 |
|c 2010
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 23.08.2012
|
500 |
|
|
|a Date Revised 21.10.2021
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status PubMed-not-MEDLINE
|
520 |
|
|
|a Although prostaglandins are largely used and considered safe drugs to induce midtrimester abortion, the literature reports several cases of uterine rupture consequent to their administration. We report the second ever-described case of uterine rupture after administration of gemeprost and sulprostone for midtrimester abortion in a 45 years-old women with scarred uterus.She was admitted to our Unit for termination at 20 weeks' gestation because of trisomy 21 diagnosed by chromosomal analysis of amniotic liquid at 16 weeks' gestation. Five pessaries of gemeprost (one pessary, every 3 hours) were administered into the posterior vaginal fornix. Since the cervix remained closed and uneffaced, another cycle of 5 gemeprost administration was conducted. When the cervix changed in consistency and dilatation, we decided to administrate sulprostone. At the obstetric examination any visible fetus was evidenced. The abdominal ultrasonography showed an empty uterine cavity and the gestational sac with the dead fetus in abdomen. Emergency laparotomy was therefore undertaken. Primary suture of the ruptured uterus was initially attempted but in vain. Therefore, total abdominal hysterectomy was performed to control bleeding and eventual hypovolemic shock.Given the lack of strong evidence in literature and the fact that case reports are not an optimal method for assessing frequency of an event nor the overall risks of a procedure since they frequently report rare single events, other larger studies are needed to assess whether women with multiple risk factors (e.g. advanced age and previous uterine surgery), and administered with prostaglandins' association have a higher risk of uterine rupture
|
650 |
|
4 |
|a Case Reports
|
650 |
|
4 |
|a gemeprost
|
650 |
|
4 |
|a pregnancy termination
|
650 |
|
4 |
|a sulprostone
|
650 |
|
4 |
|a uterine rupture.
|
700 |
1 |
|
|a La Greca, Michele
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Rapisarda, Giusi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Consoli, Daniele
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Journal of prenatal medicine
|d 2007
|g 4(2010), 1 vom: 30. Jan., Seite 9-11
|w (DE-627)NLM216403898
|x 1971-3282
|7 nnns
|
773 |
1 |
8 |
|g volume:4
|g year:2010
|g number:1
|g day:30
|g month:01
|g pages:9-11
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_31
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_72
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 4
|j 2010
|e 1
|b 30
|c 01
|h 9-11
|